No Pharma Money
David Mitchell embraced by President Biden at the White House
News & Reports

The latest from P4ADNow

The latest news, research, policy analysis, and updates from the fight to lower prescription drug prices.

Stay Up To Date

News and reports from P4ADNow

News Apr 19, 2024

This Week in Prescription Drug Pricing: Drug companies trying to stop Medicare negotiations rake in huge profits and an insulin maker’s bait and switch.

Leading drug companies are going to great lengths to protect their profits at the expense of patients.

Read Article
News Apr 12, 2024

This Week in Prescription Drug Pricing: Facts VS Pharma Fear Mongering and Becerra’s National Latino Health Tour

This year’s record investment in biotech companies directly contradicts the drug industry’s claims that the Inflation Reduction Act would stifle innovation and drug development.

Read Article
News Apr 5, 2024

This Week in Prescription Drug Pricing: Patient advocate introduces POTUS, P4AD launches new tool to defend Medicare negotiations, and how the Inflation Reduction Act is lowering drug costs for women

Kris Garcia, a husband, father of four, and a P4AD patient advocate from Colorado introduced the President at the White House on Wednesday during an event hosted by President Biden and Senator…

Read Article
News Mar 29, 2024

This Week in Prescription Drug Pricing: Lowering drug costs for patients, Teva hindering generic competition, and surging pharma CEO compensation

On Tuesday, the Department of Health & Human Services (HHS) announced a list of 41 drugs available through Medicare Part B will have a lower coinsurance rate from April 1 – June 30, 2024, should drug…

Read Article
News Mar 22, 2024

This Week in Prescription Drug Pricing: Big Pharma caught in contradiction, the growing impact of the Inflation Reduction Act, and the power of public pressure

Big drug companies continue to drum up bold lies regarding the impact of the drug price reforms in the Inflation Reduction Act (IRA).

Read Article
News Mar 15, 2024

This Week in Prescription Drug Pricing: PBM reform picks up momentum, Big Pharma lies exposed, and the legal fight over Medicare negotiation

Key Senators remain committed to advancing bipartisan bills aimed at cracking down on pharmacy benefit managers (PBMs) and their opaque tactics, which drive up costs for patients and taxpayers.

Read Article
News Mar 11, 2024

This Week in Prescription Drug Pricing: Boehringer Ingelheim caps Inhaler costs due to public pressure, Biden’s SOTU emphasized drug price reforms, and oral arguments heard in 4 cases against Medicare negotiation

In a week marked by significant developments in the fight to make medicine more affordable, Patients For Affordable Drugs Now (P4ADNow) applauded President Biden’s ongoing commitment to reducing drug…

Read Article
Press Releases Mar 8, 2024

STATEMENT: Patients For Affordable Drugs Now Applauds President Biden’s Commitment To Lowering Drug Prices At The State Of The Union Address, Looks Ahead to Future Reforms

In response to President Biden’s comments in his State of the Union address about the historic drug price reforms in the Inflation Reduction Act and the forward-looking proposals he announced to…

Read Article
Press Releases Mar 6, 2024

STATEMENT: Patients For Affordable Drugs Now Applauds President Biden’s Continued Commitment to Lower Drug Prices For Patients

Today, the Biden Administration announced proposals to more than double the number of drugs to be negotiated by Medicare and expand the $2,000 cap on out-of-pocket prescription drugs to people on…

Read Article
News Mar 2, 2024

This Week in Prescription Drug Pricing: AstraZeneca’s courtroom rejection, legislators show support for Medicare negotiation, and a new study on the high cost of insulin.

Yesterday, a federal judge in Delaware delivered a significant blow to AstraZeneca by ruling against the company in its effort to halt the negotiation of its diabetes drug, Farxiga, marking a pivotal…

Read Article
Explainers

Drug Pricing Explained

Videos breaking down the policies, practices, and decisions that shape what Americans pay for prescription drugs.

Watch The ETHIC Act Explained: What It Means for Patients on YouTube Patient advocate featured in The ETHIC Act Explained

The ETHIC Act Explained: What It Means for Patients

1:49 · Watch on YouTube

Watch How Big Pharma Games the Patent System on YouTube Merith Basey explains how Big Pharma games the patent system

How Big Pharma Games the Patent System

3:50 · Watch on YouTube

Watch Congress Delays Negotiation. Patients Pay the Price. on YouTube Dr. Ramachandran discusses delays to Medicare drug price negotiation

Congress Delays Negotiation. Patients Pay the Price.

0:51 · Watch on YouTube

Help us spread the word

Subscribe To Our YouTube
For Press

Patients are available for interviews

Looking for a patient perspective or expert comment? We can connect you with patients, policy experts, and the latest research on prescription drug pricing.

[email protected]

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.